Mark N. Tompkins 13D/13G Filings for Augmedix, Inc. (AUGX)

Mark N. Tompkins 13D and 13G filings for Augmedix, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-02-14
4:38 pm
Sale		 2022-12-31 13G Augmedix, Inc.
AUGX		 Mark N. Tompkins 914,229
2.400%		 -1,020,891decrease
(-52.76%)		 Filing
2022-02-14
4:42 pm
Purchase		 2021-12-31 13G Augmedix, Inc.
AUGX		 Mark N. Tompkins 1,935,120
5.200%		 1,935,120increase
(New Position)		 Filing